BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31445775)

  • 1. The emerging role of exosomes in multiple myeloma.
    Moloudizargari M; Abdollahi M; Asghari MH; Zimta AA; Neagoe IB; Nabavi SM
    Blood Rev; 2019 Nov; 38():100595. PubMed ID: 31445775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
    Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A
    J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs and exosomes: Small molecules with big actions in multiple myeloma pathogenesis.
    Pourhanifeh MH; Mahjoubin-Tehran M; Shafiee A; Hajighadimi S; Moradizarmehri S; Mirzaei H; Asemi Z
    IUBMB Life; 2020 Mar; 72(3):314-333. PubMed ID: 31828868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-chain polyunsaturated omega-3 fatty acids reduce multiple myeloma exosome-mediated suppression of NK cell cytotoxicity.
    Moloudizargari M; Redegeld F; Asghari MH; Mosaffa N; Mortaz E
    Daru; 2020 Dec; 28(2):647-659. PubMed ID: 32974883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-derived miR-let-7c promotes angiogenesis in multiple myeloma by polarizing M2 macrophages in the bone marrow microenvironment.
    Tian X; Sun M; Wu H; Chen C; Li H; Qiu S; Wang T; Han J; Xiao Q; Chen K
    Leuk Res; 2021 Jun; 105():106566. PubMed ID: 33848709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Progress of Exosomes in Multiple Myeloma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Strategies.
    Wang X; He L; Huang X; Zhang S; Cao W; Che F; Zhu Y; Dai J
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33915822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity.
    De Veirman K; Wang J; Xu S; Leleu X; Himpe E; Maes K; De Bruyne E; Van Valckenborgh E; Vanderkerken K; Menu E; Van Riet I
    Cancer Lett; 2016 Jul; 377(1):17-24. PubMed ID: 27102001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE2-EPC-EXs protect ageing ECs against hypoxia/reoxygenation-induced injury through the miR-18a/Nox2/ROS pathway.
    Zhang C; Wang J; Ma X; Wang W; Zhao B; Chen Y; Chen C; Bihl JC
    J Cell Mol Med; 2018 Mar; 22(3):1873-1882. PubMed ID: 29363860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total internal reflection-based single-vesicle in situ quantitative and stoichiometric analysis of tumor-derived exosomal microRNAs for diagnosis and treatment monitoring.
    He D; Wang H; Ho SL; Chan HN; Hai L; He X; Wang K; Li HW
    Theranostics; 2019; 9(15):4494-4507. PubMed ID: 31285775
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
    Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
    Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA Transfer Between Bone Marrow Adipose and Multiple Myeloma Cells.
    Soley L; Falank C; Reagan MR
    Curr Osteoporos Rep; 2017 Jun; 15(3):162-170. PubMed ID: 28432594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical Study of miRNAs Derived from Serum Exosomes in Multiple Myeloma].
    Zhou L; Liu XL; Li YW; Wu L; Wang GZ; Wang ZF; Ma L; Guan J; Han CX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1490-1495. PubMed ID: 36208254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts.
    Faict S; Muller J; De Veirman K; De Bruyne E; Maes K; Vrancken L; Heusschen R; De Raeve H; Schots R; Vanderkerken K; Caers J; Menu E
    Blood Cancer J; 2018 Nov; 8(11):105. PubMed ID: 30409995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling.
    Gupta N; Kumar R; Seth T; Garg B; Sharma A
    RNA Biol; 2020 Jan; 17(1):98-111. PubMed ID: 31532704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation.
    Raimondi L; De Luca A; Amodio N; Manno M; Raccosta S; Taverna S; Bellavia D; Naselli F; Fontana S; Schillaci O; Giardino R; Fini M; Tassone P; Santoro A; De Leo G; Giavaresi G; Alessandro R
    Oncotarget; 2015 May; 6(15):13772-89. PubMed ID: 25944696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.
    Zhang L; Pan L; Xiang B; Zhu H; Wu Y; Chen M; Guan P; Zou X; Valencia CA; Dong B; Li J; Xie L; Ma H; Wang F; Dong T; Shuai X; Niu T; Liu T
    Oncotarget; 2016 May; 7(21):30876-91. PubMed ID: 27129167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma Progression.
    Gowda PS; Wildman BJ; Trotter TN; Xu X; Hao X; Hassan MQ; Yang Y
    Mol Cancer Res; 2018 Jul; 16(7):1138-1148. PubMed ID: 29592898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Acute Myeloid Leukemia (AML)-Derived exosomes in tumor progression and survival.
    Amin AH; Sharifi LMA; Kakhharov AJ; Opulencia MJC; Alsaikhan F; Bokov DO; Majdi HS; Jawad MA; Hammid AT; Shalaby MN; Mustafa YF; Siahmansouri H
    Biomed Pharmacother; 2022 Jun; 150():113009. PubMed ID: 35486974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loading MiR-210 in Endothelial Progenitor Cells Derived Exosomes Boosts Their Beneficial Effects on Hypoxia/Reoxygeneation-Injured Human Endothelial Cells via Protecting Mitochondrial Function.
    Ma X; Wang J; Li J; Ma C; Chen S; Lei W; Yang Y; Liu S; Bihl J; Chen C
    Cell Physiol Biochem; 2018; 46(2):664-675. PubMed ID: 29621777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.
    Zhao JJ; Chu ZB; Hu Y; Lin J; Wang Z; Jiang M; Chen M; Wang X; Kang Y; Zhou Y; Ni Chonghaile T; Johncilla ME; Tai YT; Cheng JQ; Letai A; Munshi NC; Anderson KC; Carrasco RD
    Cancer Res; 2015 Oct; 75(20):4384-4397. PubMed ID: 26249174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.